Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray ; volume:12 ; number:1 ; day:4 ; month:1 ; year:2021 ; pages:1-9 ; date:12.2021
Nature Communications ; 12, Heft 1 (4.1.2021), 1-9, 12.2021
- Urheber
-
Assis, Rafael R. de
Jain, Aarti
Nakajima, Rie
Jasinskas, Algis
Felgner, Jiin
Obiero, Joshua M.
Norris, Philip J.
Stone, Mars
Simmons, Graham
Bagri, Anil
Irsch, Johannes
Schreiber, Martin
Buser, Andreas
Holbro, Andreas
Battegay, Manuel
Hosimer, Philip
Noesen, Charles
Adenaiye, Oluwasanmi
Tai, Sheldon
Hong, Filbert
Milton, Donald K.
Davies, D. Huw
Contestable, Paul
Corash, Laurence M.
Busch, Michael P.
Felgner, Philip
Khan, Saahir
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-20095-2
- URN
-
urn:nbn:de:101:1-2021020119582817886334
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Assis, Rafael R. de
- Jain, Aarti
- Nakajima, Rie
- Jasinskas, Algis
- Felgner, Jiin
- Obiero, Joshua M.
- Norris, Philip J.
- Stone, Mars
- Simmons, Graham
- Bagri, Anil
- Irsch, Johannes
- Schreiber, Martin
- Buser, Andreas
- Holbro, Andreas
- Battegay, Manuel
- Hosimer, Philip
- Noesen, Charles
- Adenaiye, Oluwasanmi
- Tai, Sheldon
- Hong, Filbert
- Milton, Donald K.
- Davies, D. Huw
- Contestable, Paul
- Corash, Laurence M.
- Busch, Michael P.
- Felgner, Philip
- Khan, Saahir
- SpringerLink (Online service)
Ähnliche Objekte (12)
The association between micronutrients and the SARS-CoV-2-specific antibodies in convalescent patients
SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
Immunological effects of convalescent plasma therapy for coronavirus: a scoping review
The Convalescent
The convalescent
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
The illustrious convalescent
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma
Coronavirus - COVID-19 - SARS-COV-2
The association between micronutrients and the SARS-CoV-2-specific antibodies in convalescent patients
SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
Immunological effects of convalescent plasma therapy for coronavirus: a scoping review
The Convalescent
The convalescent
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
The illustrious convalescent
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma
Coronavirus - COVID-19 - SARS-COV-2
The association between micronutrients and the SARS-CoV-2-specific antibodies in convalescent patients
SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
Immunological effects of convalescent plasma therapy for coronavirus: a scoping review
The Convalescent
The convalescent
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
The illustrious convalescent
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma